+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Preclinical Imaging (In-VIVO) - Market Analysis, Trends, and Forecasts

  • ID: 4805695
  • Report
  • October 2019
  • Region: Global
  • 88 pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Aspect Imaging
  • Bruker Corporation
  • Mediso
  • Milabs Bv
  • Miltenyi Biotec Gmbh
  • Mr Solutions
  • MORE
The Preclinical Imaging (In-VIVO) market worldwide is projected to grow by US$361.3 Million, driven by a compounded growth of 5.9%. Preclinical imaging modalities, one of the segments analyzed and sized in this study, displays the potential to grow at over 6.3%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$686 Million by the year 2025, Preclinical imaging modalities will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$16.7 Million to the region's size and clout in the next 5 to 6 years. Over US$16.9 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Preclinical imaging modalities will reach a market size of US$53.3 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 5.7% over the next couple of years and add approximately US$62.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Aspect Imaging
  • Bruker Corporation
  • FUJIFILM Holdings Corporation
  • LI-COR, Inc. (LI-COR Biosciences)
  • Mediso Ltd.
  • MILabs BV
  • Miltenyi Biotec GmbH
  • MR Solutions Ltd.
  • PerkinElmer, Inc.
  • Trifoil Imaging, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aspect Imaging
  • Bruker Corporation
  • Mediso
  • Milabs Bv
  • Miltenyi Biotec Gmbh
  • Mr Solutions
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Preclinical Imaging (In-VIVO) Competitor Market Share Scenario Worldwide (in %): 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Preclinical Imaging (In-VIVO) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Preclinical Imaging (In-VIVO) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Preclinical Imaging (In-VIVO) Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Preclinical imaging modalities (Segment) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 5: Preclinical imaging modalities (Segment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 6: Preclinical imaging modalities (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Preclinical imaging reagents (Segment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 8: Preclinical imaging reagents (Segment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 9: Preclinical imaging reagents (Segment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Preclinical Imaging (In-VIVO) Market Share (in %) by Company: 2019 & 2025

TABLE 10: United States Preclinical Imaging (In-VIVO) Market Estimates and Projections in US$ Thousand by Segment: 2018 to 2025

TABLE 11: Preclinical Imaging (In-VIVO) Market in the United States by Segment: A Historic Review in US$ Thousand for 2009-2017

TABLE 12: United States Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

CANADA

TABLE 13: Canadian Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025

TABLE 14: Canadian Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017

TABLE 15: Preclinical Imaging (In-VIVO) Market in Canada: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

JAPAN

TABLE 16: Japanese Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025

TABLE 17: Preclinical Imaging (In-VIVO) Market in Japan: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017

TABLE 18: Japanese Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025

CHINA

TABLE 19: Chinese Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025

TABLE 20: Preclinical Imaging (In-VIVO) Historic Market Analysis in China in US$ Thousand by Segment: 2009-2017

TABLE 21: Chinese Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Preclinical Imaging (In-VIVO) Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 22: European Preclinical Imaging (In-VIVO) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 23: Preclinical Imaging (In-VIVO) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 24: European Preclinical Imaging (In-VIVO) Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: European Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025

TABLE 26: Preclinical Imaging (In-VIVO) Market in Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017

TABLE 27: European Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

FRANCE

TABLE 28: Preclinical Imaging (In-VIVO) Market in France by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 29: French Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017

TABLE 30: French Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025

GERMANY

TABLE 31: Preclinical Imaging (In-VIVO) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Segment for the Period 2018-2025

TABLE 32: German Preclinical Imaging (In-VIVO) Historic Market Analysis in US$ Thousand by Segment: 2009-2017

TABLE 33: German Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

ITALY

TABLE 34: Italian Preclinical Imaging (In-VIVO) Market Growth Prospects in US$ Thousand by Segment for the Period 2018-2025

TABLE 35: Preclinical Imaging (In-VIVO) Historic Market Analysis in Italy in US$ Thousand by Segment: 2009-2017

TABLE 36: Italian Preclinical Imaging (In-VIVO) Market by Segment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 37: United Kingdom Market for Preclinical Imaging (In-VIVO): Annual Sales Estimates and Projections in US$ Thousand by Segment for the Period 2018-2025

TABLE 38: Preclinical Imaging (In-VIVO) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Segment for the Period 2009-2017

TABLE 39: United Kingdom Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 40: Rest of Europe Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018-2025

TABLE 41: Preclinical Imaging (In-VIVO) Market in Rest of Europe in US$ Thousand by Segment: A Historic Review for the Period 2009-2017

TABLE 42: Rest of Europe Preclinical Imaging (In-VIVO) Market Share Breakdown by Segment: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 43: Preclinical Imaging (In-VIVO) Market in Asia-Pacific by Segment: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 44: Asia-Pacific Preclinical Imaging (In-VIVO) Historic Market Scenario in US$ Thousand by Segment: 2009-2017

TABLE 45: Asia-Pacific Preclinical Imaging (In-VIVO) Market Share Analysis by Segment: 2009 VS 2019 VS 2025

REST OF WORLD

TABLE 46: Rest of World Preclinical Imaging (In-VIVO) Market Estimates and Forecasts in US$ Thousand by Segment: 2018 to 2025

TABLE 47: Rest of World Preclinical Imaging (In-VIVO) Historic Market Review by Segment in US$ Thousand: 2009-2017

TABLE 48: Preclinical Imaging (In-VIVO) Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2009, 2019, and 2025

IV. COMPETITION

ASPECT IMAGING

BRUKER CORPORATION

FUJIFILM HOLDINGS CORPORATION

LI-COR, INC. (LI-COR BIOSCIENCES)

MILABS BV

MR SOLUTIONS

MEDISO

MILTENYI BIOTEC GMBH

PERKINELMER

TRIFOIL IMAGING

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aspect Imaging
  • Bruker Corporation
  • Fujifilm Holdings Corporation
  • Li-Cor, Inc. (Li-Cor Biosciences)
  • Milabs Bv
  • Mr Solutions
  • Mediso
  • Miltenyi Biotec Gmbh
  • Perkinelmer
  • Trifoil Imaging
Note: Product cover images may vary from those shown
Adroll
adroll